40 results on '"Grimmler M"'
Search Results
2. A-072 An All-Purpose Particle Enhanced Immunoturbidimetric Assay for the Comparable, Instrument-Independent Monitoring of Procalcitonin in the Management of Sepsis
- Author
-
Grimmler, M, primary
- Published
- 2023
- Full Text
- View/download PDF
3. Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays
- Author
-
Dikaios, I., Althaus, H., Angles-Cano, E., Ceglarek, U., Coassin, S., Cobbaert, C.M., Delatour, V., Dieplinger, B., Grimmler, M., Hoofnagle, A.N., Kostner, G.M., Kronenberg, F., Kuklenyik, Z., Lyle, A.N., Prinzing, U., Ruhaak, L.R., Scharnagl, H., Vesper, H.W., Deprez, L., and IFCC Working Grp Apolipoprot Mass
- Subjects
Biochemistry (medical) ,Clinical Biochemistry - Abstract
BackgroundElevated concentrations of lipoprotein(a) [Lp(a)] are directly related to an increased risk of cardiovascular diseases, making it a relevant biomarker for clinical risk assessment. However, the lack of global standardization of current Lp(a) measurement procedures (MPs) leads to inconsistent patient care. The International Federation for Clinical Chemistry and Laboratory Medicine working group on quantitating apolipoproteins by mass spectrometry (MS) aims to develop a next-generation SI (International system of units)-traceable reference measurement system consisting of a MS-based, peptide-calibrated reference measurement procedure (RMP) and secondary serum-based reference materials (RMs) certified for their apolipoprotein(a) [apo(a)] content. To reach measurement standardization through this new measurement system, 2 essential requirements need to be fulfilled: a sufficient correlation among the MPs and appropriate commutability of future serum-based RMs.MethodsThe correlation among the candidate RMP (cRMP) and immunoassay-based MPs was assessed by measuring a panel of 39 clinical samples (CS). In addition, the commutability of 14 different candidate RMs was investigated.ResultsResults of the immunoassay-based MPs and the cRMPs demonstrated good linear correlations for the CS but some significant sample-specific differences were also observed. The results of the commutability study show that RMs based on unspiked human serum pools can be commutable with CS, whereas human pools spiked with recombinant apo(a) show different behavior compared to CS.ConclusionsThe results of this study show that unspiked human serum pools are the preferred candidate secondary RMs in the future SI-traceable Lp(a) Reference Measurement System.
- Published
- 2023
4. M079 Evaluation of a new accurate and reliable particle enhanced immunoturbidimetric assay for the detection of Procalcitonin in the management of sepsis
- Author
-
Masetto, T., primary, Kochem, C., additional, Ziska, D., additional, Tölke, S., additional, Bäcker, A., additional, Delseith-Hermsdorf, I., additional, and Grimmler, M., additional
- Published
- 2022
- Full Text
- View/download PDF
5. IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients
- Author
-
Thompson, S., primary, Bohn, M.K., additional, Mancini, N., additional, Loh, T., additional, Wang, C., additional, Grimmler, M., additional, Yuen, K., additional, Mueller, R., additional, Koch, D., additional, Sethi,, S., additional, Rawlinson, W., additional, Clementi,, M., additional, Erasmus, R., additional, Leportier, M., additional, Kwon, G., additional, Menezes, M.E., additional, Patru, M., additional, Gramegna, M., additional, Singh, K., additional, Najjar, O., additional, Ferrari,, M., additional, Lippi, G., additional, Adeli,, K., additional, and Horvath, A., additional
- Published
- 2021
- Full Text
- View/download PDF
6. Measurement of Lipoprotein (a) using the binding site Optilite® turbidimetric analyzer and Lipoprotein (a) assay
- Author
-
Brook, H., primary, Caspari, S., additional, Weber, B., additional, Grimmler, M., additional, Murphy, F., additional, Mccusker, M., additional, Matters, D., additional, and Harding, S., additional
- Published
- 2019
- Full Text
- View/download PDF
7. Apolipoprotein B assay performance on the binding site Optilite® turbidimetric analyzer
- Author
-
Sroa, B., primary, Weber, B., additional, Grimmler, M., additional, Murphy, F., additional, Matters, D., additional, and Harding, S., additional
- Published
- 2019
- Full Text
- View/download PDF
8. Apolipoprotein A-1 assay performance on the binding site Optilite® turbidimetric analyzer
- Author
-
Aldridge, C., primary, Weber, B., additional, Grimmler, M., additional, Sroa, B., additional, Murphy, F., additional, Matters, D., additional, and Harding, S., additional
- Published
- 2019
- Full Text
- View/download PDF
9. IGE assay performance on the binding site Optilite® analyzer
- Author
-
Seibaka, J., primary, Aldridge, C., additional, Caspari, S., additional, Weber, B., additional, Grimmler, M., additional, Sroa, B., additional, Murphy, F., additional, Mccusker, M., additional, Matters, D., additional, and Harding, S., additional
- Published
- 2019
- Full Text
- View/download PDF
10. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy
- Author
-
Sun, Y., primary, Grimmler, M., additional, Schwarzer, V., additional, Schoenen, F., additional, Fischer, U., additional, and Wirth, B., additional
- Published
- 2005
- Full Text
- View/download PDF
11. Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination.
- Author
-
Schest S, Langer C, Stiegler Y, Karnuth B, Arends J, Stiegler H, Masetto T, Peter C, and Grimmler M
- Subjects
- Humans, BNT162 Vaccine, SARS-CoV-2, Epitopes, ChAdOx1 nCoV-19, Pandemics, COVID-19 Serotherapy, Immunoglobulin Isotypes, Antibodies, Viral, COVID-19, Vaccines
- Abstract
Background: Quantification of the SARS-CoV-2-specific immune response by serological immunoassays is critical for the management of the COVID-19 pandemic. In particular, neutralizing antibody titers to the viral spike (S) protein have been proposed as a correlate of protection (CoP). The WHO established the First International Standard (WHO IS) for anti-SARS-CoV-2 immunoglobulin (Ig) (NIBSC 20/136) to harmonize binding assays with the same antigen specificity by assigning the same unitage in binding antibody units (BAU)/ml., Method: In this study, we analyzed the S1-specific antibody response in a cohort of healthcare workers in Germany (n = 76) during a three-dose vaccination course over 8.5 months. Subjects received either heterologous or homologous prime-boost vaccination with ChAdOx1 nCoV-19 (AstraZeneca) and BNT162b2 (Pfizer-BioNTech) or three doses of BNT162b2. Antibodies were quantified using three anti-S1 binding assays (ELISA, ECLIA, and PETIA) harmonized to the WHO IS. Serum levels of neutralizing antibodies were determined using a surrogate virus neutralization test (sVNT). Binding assays were compared using Spearman's rank correlation and Passing-Bablok regression., Findings: All assays showed good correlation and similar antibody kinetics correlating with neutralizing potential. However, the assays show large proportional differences in BAU/ml. ECLIA and PETIA, which detect total antibodies against the receptor- binding domain (RBD) within the S1 subunit, interact similarly with the convalescent plasma-derived WHO IS but differently with vaccine serum, indicating a high sensitivity to the IgG/IgM/IgA ratio., Conclusion: All three binding assays allow monitoring of the antibody response in COVID-19-vaccinated individuals. However, the assay-specific differences hinder the definition of a common protective threshold in BAU/ml. Our results highlight the need for the thoughtful use of conversion factors and consideration of method-specific differences. To improve the management of future pandemics and harmonize total antibody assays, we should strive for reference material with a well-characterized Ig isotype composition., Competing Interests: Authors SS, CL, YS, BK, JA, and HS are employed at Medizinisches Versorgungszentrum für Labormedizin und Mikrobiologie Ruhr GmbH Essen, Germany. MG is employed at DiaServe Laboratories GmbH Iffeldorf, Germany. MG and TM are employees of DiaSys Diagnostic GmbH Holzheim, Germany and are named as inventors on a patent application Deutsche Patentanmeldung 10 2020 122 593.8 claiming the manufacturing and use of the described PETIA for serological quantification of anti-SARS-CoV-2 antibodies. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Schest, Langer, Stiegler, Karnuth, Arends, Stiegler, Masetto, Peter and Grimmler.)
- Published
- 2023
- Full Text
- View/download PDF
12. The Impact of p70S6 Kinase-Dependent Phosphorylation of Gemin2 in UsnRNP Biogenesis.
- Author
-
Esser LM, Li Q, Jüdt M, Kähne T, Stork B, Grimmler M, Wesselborg S, and Peter C
- Subjects
- Cyclic AMP Response Element-Binding Protein metabolism, Phosphorylation, Ribonucleoproteins, Small Nuclear genetics, SMN Complex Proteins genetics, Uridine metabolism, Ribosomal Protein S6 Kinases, 70-kDa metabolism, RNA-Binding Proteins metabolism
- Abstract
The survival motor neuron (SMN) complex is a multi-megadalton complex involved in post-transcriptional gene expression in eukaryotes via promotion of the biogenesis of uridine-rich small nuclear ribonucleoproteins (UsnRNPs). The functional center of the complex is formed from the SMN/Gemin2 subunit. By binding the pentameric ring made up of the Sm proteins SmD1/D2/E/F/G and allowing for their transfer to a uridine-rich short nuclear RNA (UsnRNA), the Gemin2 protein in particular is crucial for the selectivity of the Sm core assembly. It is well established that post-translational modifications control UsnRNP biogenesis. In our work presented here, we emphasize the crucial role of Gemin2, showing that the phospho-status of Gemin2 influences the capacity of the SMN complex to condense in Cajal bodies (CBs) in vivo. Additionally, we define Gemin2 as a novel and particular binding partner and phosphorylation substrate of the mTOR pathway kinase ribosomal protein S6 kinase beta-1 (p70S6K). Experiments using size exclusion chromatography further demonstrated that the Gemin2 protein functions as a connecting element between the 6S complex and the SMN complex. As a result, p70S6K knockdown lowered the number of CBs, which in turn inhibited in vivo UsnRNP synthesis. In summary, these findings reveal a unique regulatory mechanism of UsnRNP biogenesis.
- Published
- 2023
- Full Text
- View/download PDF
13. Immunoaffinity LC-MS/MS Quantification of the Sepsis Biomarker Procalcitonin Using Magnetic- and Polystyrene-Bead Immobilized Polyclonal Antibodies.
- Author
-
Tölke SA, Masetto T, Reuschel T, Grimmler M, Bindila L, and Schneider K
- Subjects
- Humans, Polystyrenes therapeutic use, Chromatography, Liquid methods, Tandem Mass Spectrometry methods, Biomarkers, Antibodies, Peptides, Magnetic Phenomena, Procalcitonin therapeutic use, Sepsis diagnosis
- Abstract
Procalcitonin (PCT) is a biomarker for bacterial sepsis, and accurate quantification of PCT is critical for sepsis diagnosis and treatment. Immunological PCT quantification methods are routinely used in clinical laboratories, yet there is a need for harmonization of PCT quantification protocols. An orthogonal method to clinical immunological assays, such as LC-MS/MS, is required. In this study, a highly sensitive and robust immunoaffinity LC-MRM quantitative method for detecting procalcitonin in human serum has been developed. An initial comparison of immunocapture of PCT with a polyclonal anti-PCT antibody immobilized on polystyrene nanoparticles (Latex) and magnetic beads demonstrated superior performance with magnetic beads. Three tryptic PCT peptides from the N- and C-terminal regions of PCT were selected for LC-MS/MS quantification. For PCT quantification, an LLOQ of 0.25 ng/mL of PCT in human serum was achieved using a sample volume of 1 mL. The method's trueness and precision consistently lie within the 15% margin. The parallel measurement of three PCT peptides may allow future differentiation of intact PCT vs other PCT forms originating from potential degradation, processing, or polymorphisms. An established and validated LC-MRM-based quantification of PCT will be relevant as an orthogonal method for harmonization and standardization of clinical assays for PCT.
- Published
- 2023
- Full Text
- View/download PDF
14. Comment to: Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor.
- Author
-
Masetto T and Grimmler M
- Subjects
- Humans, Biological Assay, Biomarkers, Calcitonin, Calcitonin Gene-Related Peptide
- Published
- 2023
- Full Text
- View/download PDF
15. Comprehensive Comparison of the Capacity of Functionalized Sepharose, Magnetic Core, and Polystyrene Nanoparticles to Immuno-Precipitate Procalcitonin from Human Material for the Subsequent Quantification by LC-MS/MS.
- Author
-
Masetto T, Matzenbach K, Reuschel T, Tölke SA, Schneider K, Esser LM, Reinhart M, Bindila L, Peter C, and Grimmler M
- Subjects
- Humans, Procalcitonin, Sepharose, Chromatography, Liquid, HeLa Cells, Polystyrenes, Proteomics, Tandem Mass Spectrometry, Antibodies, Magnetic Phenomena, Biomarkers, Sepsis diagnosis, Nanoparticles
- Abstract
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The fast and accurate diagnosis of sepsis by procalcitonin (PCT) has emerged as an essential tool in clinical medicine. Although in use in the clinical laboratory for a long time, PCT quantification has not yet been standardized. The International Federation of Clinical Chemistry working group on the standardization of PCT (IFCC-WG PCT) aims to provide an LC-MS/MS-based reference method as well as the highest metrological order reference material to address this diagnostic need. Here, we present the systematic evaluation of the efficiency of an immuno-enrichment method, based on functionalized Sepharose, magnetic-core, or polystyrene (latex) nano-particles, to quantitatively precipitate PCT from different human sample materials. This method may be utilized for both mass spectrometric and proteomic purposes. In summary, only magnetic-core nano-particles functionalized by polyclonal PCT antibodies can fulfil the necessary requirements of the international standardization of PCT. An optimized method proved significant benefits in quantitative and specific precipitation as well as in the subsequent LC-MS/MS detection of PCT in human serum samples or HeLa cell extract. Based on this finding, further attempts of the PCT standardization process will utilize a magnetic core-derived immuno-enrichment step, combined with subsequent quantitative LC-MS/MS detection.
- Published
- 2023
- Full Text
- View/download PDF
16. Phosphorylation of pICln by the autophagy activating kinase ULK1 regulates snRNP biogenesis and splice activity of the cell.
- Author
-
Esser LM, Schmitz K, Hillebrand F, Erkelenz S, Schaal H, Stork B, Grimmler M, Wesselborg S, and Peter C
- Abstract
The spliceosome, responsible for all mature protein-coding transcripts of eukaryotic intron-containing genes, consists of small uridine-rich nuclear ribonucleoproteins (UsnRNPs). The assembly of UsnRNPs depends, on one hand, on the arginine methylation of Sm proteins catalyzed by the PRMT5 complex. On the other hand, it depends on the phosphorylation of the PRMT5 subunit pICln by the Uncoordinated Like Kinase 1 (ULK1). In consequence, phosphorylation of pICln affects the stability of the UsnRNP assembly intermediate, the so-called 6 S complex. The detailed mechanisms of phosphorylation-dependent integrity and subsequent UsnRNP assembly of the 6 S complex in vivo have not yet been analyzed. By using a phospho-specific antibody against ULK1-dependent phosphorylation sites of pICln, we visualize the intracellular distribution of phosphorylated pICln. Furthermore, we detect the colocaliphosphor-pICln1 with phospho-pICln by size-exclusion chromatography and immunofluorescence techniques. We also show that phosphorylated pICln is predominantly present in the 6 S complex. The addition of ULK1 to in vitro produced 6 S complex, as well as the reconstitution of ULK1 in ULK1-deficient cells, increases the efficiency of snRNP biogenesis. Accordingly, inhibition of ULK1 and the associated decreased pICln phosphorylation lead to accumulation of the 6 S complex and reduction in the spliceosomal activity of the cell., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.)
- Published
- 2023
- Full Text
- View/download PDF
17. Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2.
- Author
-
Wey L, Masetto T, Spaeth A, Brehm J, Kochem C, Reinhart M, Müller H, Kempin U, Lorenz F, Peter C, and Grimmler M
- Abstract
Since SARS-CoV-2 emerged in December 2019 in Wuhan, the resulting pandemic has paralyzed the economic and cultural life of the world. Variants of concern (VOC) strongly increase pressure on public health systems. Rapid, easy-to-use, and cost-effective assays are essential to manage the pandemic. Here we present a bioinformatical approach for the fast and efficient design of two innovative serological Particle Enhanced Turbidimetric Immunoassays (PETIA) to quantify the SARS-CoV-2 immunoresponse. To confirm bioinformatical assumptions, an S-RBD- and a Nucleocapsid-based PETIA were produced. Sensitivity and specificity were compared for 95 patient samples using a BioMajesty™ fully automated analyzer. The S-RBD-based PETIA showed necessary specificity (98%) over the N protein-based PETIA (21%). Further, the reactivity and cross-reactivity of the RBD-based PETIA towards variant-derived antibodies of SARS-CoV-2 were assessed by a quenching inhibition test. The inhibition kinetics of the S-RBD variants Alpha , Beta , Delta , Gamma , Kappa , and Omicron were evaluated. In summary, we showed that specific and robust PETIA immunoassays can be rapidly designed and developed. The quantification of the SARS-CoV-2-related immunoresponse of variants ( Alpha to Kappa ) is possible using specific RBD assays. In contrast, Omicron revealed lower cross-reactivity (approx. 50%). To ensure the quantification of the Omicron variant, modified immunoassays appear to be necessary.
- Published
- 2023
- Full Text
- View/download PDF
18. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex.
- Author
-
Cox J, Esser LM, Jüdt M, Schmitz K, Reiffert K, Grimmler M, Stork B, Wesselborg S, and Peter C
- Subjects
- Animals, Arginine metabolism, Mammals metabolism, Methylation, Protein Processing, Post-Translational, Nuclear Factor 90 Proteins genetics, Nuclear Factor 90 Proteins metabolism, Protein-Arginine N-Methyltransferases genetics, Protein-Arginine N-Methyltransferases metabolism
- Abstract
Protein-arginine methylation is a common posttranslational modification, crucial to various cellular processes, such as protein-protein interactions or binding to nucleic acids. The central enzyme of symmetric protein arginine methylation in mammals is the protein arginine methyltransferase 5 (PRMT5). While the methylation reaction itself is well understood, recruitment and differentiation among substrates remain less clear. One mechanism to regulate the diversity of PRMT5 substrate recognition is the mutual binding to the adaptor proteins pICln or RioK1. Here, we describe the specific interaction of Nuclear Factor 90 (NF90) with the PRMT5-WD45-RioK1 complex. We show for the first time that NF90 is symmetrically dimethylated by PRMT5 within the RG-rich region in its C-terminus. Since upregulation of PRMT5 is a hallmark of many cancer cells, the characterization of its dimethylation and modulation by specific commercial inhibitors in vivo presented here may contribute to a better understanding of PRMT5 function and its role in cancer., (© 2022 the author(s), published by De Gruyter, Berlin/Boston.)
- Published
- 2022
- Full Text
- View/download PDF
19. SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study.
- Author
-
Brehm J, Spaeth A, Dreßler L, Masetto T, Dannenberg R, Peter C, and Grimmler M
- Subjects
- Antibodies, Viral, Humans, Pandemics, SARS-CoV-2, Post-Acute COVID-19 Syndrome, COVID-19 complications
- Abstract
Background: Since December 2019, SARS-CoV-2 has been keeping the world in suspense. Rapid tests, molecular diagnosis of acute infections, and vaccination campaigns with vaccines are building blocks of strategic pandemic control worldwide. For laboratory diagnostics, the quantification of the antibody titer of convalescents and vaccinated patients is thus increasingly coming to the fore., Methods: Here we present an evaluation on the comparability of five serological tests on a cohort of 13 patients with mild COVID-19 disease. Also participants who were vaccinated after recovery were included in this study. All common immune methods (ELISA, CLIA, PETIA) and SARS-CoV-2 specific antigens (N-, S1- and RBD-) were specifically tracked and directly compared for up to 455 days. The titer of recovered participants was also set to the degree of symptoms during infection and the occurrence of Long-COVID. In addition, relative comparability of different serological tests, all standardized to WHO, was set in reference to the neutralizing potential of the corresponding participants., Findings: The individual immune responses over 455 days after a mild SARS-CoV-2 infection remain stable, in contrast to vaccinated participants. All sero-tests reveal comparable performance and dynamics during the study and compared well to a surrogate neutralization test., Conclusion: The information presented here will help clinicians in the daily laboratory work in the selection and evaluation of different serological tests offered. The data also will support in respect of a sero-test-based neutralization cutoff., Competing Interests: Authors JB, AS, LD, RD are employed by MVZ Medizinische Labore Dessau Kassel GmbH. Authors TM and MG are employees of DiaSys Diagnostic GmbH and are named as inventors on a patent application (Deutsche Patentanmeldung 10 2020 122 593.8), claiming the manufacturing and use of the described PETIA for serological quantification of SARS-CoV-2 antigens. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The PETIA SARS-CoV-2 UTAB FS assay used in this study was kindly provided by DiaSys Diagnostic Systems GmbH, Holzheim, Germany., (Copyright © 2022 Brehm, Spaeth, Dreßler, Masetto, Dannenberg, Peter and Grimmler.)
- Published
- 2022
- Full Text
- View/download PDF
20. National external quality assessment and direct method comparison reflect crucial deviations of Procalcitonin measurements in Germany.
- Author
-
Masetto T, Eidizadeh A, Peter C, and Grimmler M
- Subjects
- Biomarkers, Humans, Immunoassay methods, Reference Standards, Procalcitonin, Sepsis diagnosis
- Abstract
Background and Aims: Sepsis is a major concern worldwide, affecting 49 million individuals and being related to 11 million deaths. Its fast diagnosis is the key factor to guarantee a positive prognosis. Procalcitonin (PCT) has emerged as one powerful biomarker to early diagnose sepsis and for monitoring of antibiotic treatment. However, its clinical utility is jeopardized by missing standardisation., Materials and Methods: Here we present a 1-year follow-up of the External Quality Assessment (EQA) in Germany, depicting substantial discrepancies among manufacturers and the used assay technology of current PCT measurements. A direct method comparison on two immunoassays (Abbott vs. DiaSys) on a set of 135 routine samples was used to analyse the causes of observed deviations., Results: All BRAHMS-licensed manufacturers (Thermo, Roche, Abbott, Siemens, Biomérieux), the Beckman and DiaSys immunoassays as well as all assay types (fluorescence, luminescence, PETIA) reveal substantial recovery differences between each other. However, upon a non-linear re-standardization of calibrators, the two directly compared methods (Abbott, DiaSys) are well interchangeable., Conclusion: This work demonstrates the heterogenic situation of PCT measurements in Germany among manufacturers and all methods. By introducing dedicated correction factors, comparable results of PCT can be achieved. This work also strengthens the inevitability of calibrator traceability and higher metrological reference materials on PCT., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
21. Letter to the Editor regarding "Development of an antibody-free ID-LC MS method for the quantification of procalcitonin in human serum at sub-microgram per liter level using a peptide-based calibration".
- Author
-
Tölke SA, Masetto T, Grimmler M, Bindila L, and Schneider K
- Subjects
- Calibration, Chromatography, Liquid, Humans, Mass Spectrometry, Peptides, Procalcitonin
- Published
- 2021
- Full Text
- View/download PDF
22. Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays.
- Author
-
Spaeth A, Masetto T, Brehm J, Wey L, Kochem C, Brehm M, Peter C, and Grimmler M
- Abstract
In 2019, a novel coronavirus emerged in Wuhan in the province of Hubei, China. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly spread across the globe, causing the neoteric COVID-19 pandemic. SARS-CoV-2 is commonly transmitted by droplet infection and aerosols when coughing or sneezing, as well as high-risk exposures to infected individuals by face-to-face contact without protective gear. To date, a broad variety of techniques have emerged to assess and quantify the specific antibody response of a patient towards a SARS-CoV-2 infection. Here, we report the first comprehensive comparison of five different assay systems: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Electro-Chemiluminescence Immunoassay (ECLIA), and a new Particle-Enhanced Turbidimetric Immunoassay (PETIA) for SARS-CoV-2. Furthermore, we also evaluated the suitability of N-, S1- and RBD-antigens for quantifying the SARS-CoV-2 specific immune response. Linearity and precision, overall sensitivity and specificity of the assays, stability of samples, and cross-reactivity of general viral responses, as well as common coronaviruses, were assessed. Moreover, the reactivity of all tests to seroconversion and different sample matrices was quantified. All five assays showed good overall agreement, with 76% and 87% similarity for negative and positive samples, respectively. In conclusion, all evaluated methods showed a high consistency of results and suitability for the robust quantification of the SARS-CoV-2-derived immune response.
- Published
- 2021
- Full Text
- View/download PDF
23. An essential role of the autophagy activating kinase ULK1 in snRNP biogenesis.
- Author
-
Schmitz K, Cox J, Esser LM, Voss M, Sander K, Löffler A, Hillebrand F, Erkelenz S, Schaal H, Kähne T, Klinker S, Zhang T, Nagel-Steger L, Willbold D, Seggewiß S, Schlütermann D, Stork B, Grimmler M, Wesselborg S, and Peter C
- Subjects
- Autophagy-Related Protein-1 Homolog antagonists & inhibitors, Autophagy-Related Protein-1 Homolog physiology, Cell Line, Coiled Bodies, Humans, Intracellular Signaling Peptides and Proteins antagonists & inhibitors, Intracellular Signaling Peptides and Proteins physiology, Ion Channels metabolism, Phosphorylation, Protein-Arginine N-Methyltransferases metabolism, Autophagy-Related Protein-1 Homolog metabolism, Intracellular Signaling Peptides and Proteins metabolism, Ribonucleoproteins, Small Nuclear biosynthesis
- Abstract
The biogenesis of small uridine-rich nuclear ribonucleoproteins (UsnRNPs) depends on the methylation of Sm proteins catalyzed by the methylosome and the subsequent action of the SMN complex, which assembles the heptameric Sm protein ring onto small nuclear RNAs (snRNAs). In this sophisticated process, the methylosome subunit pICln (chloride conductance regulatory protein) is attributed to an exceptional key position as an 'assembly chaperone' by building up a stable precursor Sm protein ring structure. Here, we show that-apart from its autophagic role-the Ser/Thr kinase ULK1 (Uncoordinated [unc-51] Like Kinase 1) functions as a novel key regulator in UsnRNP biogenesis by phosphorylation of the C-terminus of pICln. As a consequence, phosphorylated pICln is no longer capable to hold up the precursor Sm ring structure. Consequently, inhibition of ULK1 results in a reduction of efficient UsnRNP core assembly. Thus ULK1, depending on its complex formation, exerts different functions in autophagy or snRNP biosynthesis., (© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2021
- Full Text
- View/download PDF
24. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals.
- Author
-
Bohn MK, Lippi G, Horvath AR, Erasmus R, Grimmler M, Gramegna M, Mancini N, Mueller R, Rawlinson WD, Menezes ME, Patru MM, Rota F, Sethi S, Singh K, Yuen KY, Wang CB, and Adeli K
- Subjects
- Asymptomatic Infections classification, COVID-19 immunology, COVID-19 virology, Humans, Antigens, Viral immunology, COVID-19 diagnosis, Immunoassay standards, Point-of-Care Testing standards, Practice Guidelines as Topic standards, SARS-CoV-2 immunology, SARS-CoV-2 isolation & purification
- Abstract
With an almost unremittent progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections all around the world, there is a compelling need to introduce rapid, reliable, and high-throughput testing to allow appropriate clinical management and/or timely isolation of infected individuals. Although nucleic acid amplification testing (NAAT) remains the gold standard for detecting and theoretically quantifying SARS-CoV-2 mRNA in various specimen types, antigen assays may be considered a suitable alternative, under specific circumstances. Rapid antigen tests are meant to detect viral antigen proteins in biological specimens (e.g. nasal, nasopharyngeal, saliva), to indicate current SARS-CoV-2 infection. The available assay methodology includes rapid chromatographic immunoassays, used at the point-of-care, which carries some advantages and drawbacks compared to more conventional, instrumentation-based, laboratory immunoassays. Therefore, this document by the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) Taskforce on COVID-19 aims to summarize available data on the performance of currently available SARS-CoV-2 antigen rapid detection tests (Ag-RDTs), providing interim guidance on clinical indications and target populations, assay selection, and evaluation, test interpretation and limitations, as well as on pre-analytical considerations. This document is hence mainly aimed to assist laboratory and regulated health professionals in selecting, validating, and implementing regulatory approved Ag-RDTs., (© 2021 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2021
- Full Text
- View/download PDF
25. IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2.
- Author
-
Bohn MK, Loh TP, Wang CB, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Grimmler M, Yuen KY, Mancini N, Kwon GC, Menezes ME, Patru MM, Gramegna M, Singh K, Najjar O, Ferrari M, Horvath AR, Lippi G, and Adeli K
- Subjects
- Antibodies, Viral immunology, Humans, SARS-CoV-2, Antibodies, Viral blood, Betacoronavirus immunology, International Agencies, Practice Guidelines as Topic, Serologic Tests methods
- Abstract
Serological testing for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging as an important component of the clinical management of patients with coronavirus disease 2019 (COVID-19) as well as the epidemiological assessment of SARS-CoV-2 exposure worldwide. In addition to molecular testing for the detection of SARS-CoV-2 infection, clinical laboratories have also needed to increase testing capacity to include serological evaluation of patients with suspected or known COVID-19. While regulatory approved serological immunoassays are now widely available from diagnostic manufacturers globally, there is significant debate regarding the clinical utility of these tests, as well as their clinical and analytical performance requirements prior to application. This document by the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) Taskforce on COVID-19 provides interim guidance on: (A) clinical indications and target populations, (B) assay selection, (C) assay evaluation, and (D) test interpretation and limitations for serological testing of antibodies against SARS-CoV-2 infection. These evidence-based recommendations will provide practical guidance to clinical laboratories in the selection, verification, and implementation of serological assays and are of the utmost importance as we expand our pandemic response from initial case tracing and containment to mitigation strategies to minimize resurgence and further morbidity and mortality.
- Published
- 2020
- Full Text
- View/download PDF
26. IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients.
- Author
-
Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, Yuen KY, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Kwon GC, Menezes ME, Patru MM, Gramegna M, Singh K, Najjar O, Ferrari M, Lippi G, Adeli K, and Horvath AR
- Subjects
- Adult, Biomarkers blood, COVID-19, Cardiovascular Diseases complications, Child, Coronavirus Infections blood, Coronavirus Infections complications, Female, Humans, Male, Multiple Organ Failure complications, Pandemics, Pneumonia, Viral blood, Pneumonia, Viral complications, Coronavirus Infections metabolism, Hematologic Tests, International Agencies, Pneumonia, Viral metabolism, Practice Guidelines as Topic
- Abstract
Routine biochemical and hematological tests have been reported to be useful in the stratification and prognostication of pediatric and adult patients with diagnosed coronavirus disease (COVID-19), correlating with poor outcomes such as the need for mechanical ventilation or intensive care, progression to multisystem organ failure, and/or death. While these tests are already well established in most clinical laboratories, there is still debate regarding their clinical value in the management of COVID-19, particularly in pediatrics, as well as the value of composite clinical risk scores in COVID-19 prognostication. This document by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 provides interim guidance on: (A) clinical indications for testing, (B) recommendations for test selection and interpretation, (C) considerations in test interpretation, and (D) current limitations of biochemical/hematological monitoring of COVID-19 patients. These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide, underscoring the contribution of biochemical and hematological testing to our collective pandemic response.
- Published
- 2020
- Full Text
- View/download PDF
27. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection.
- Author
-
Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, Gramegna M, Yuen KY, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Kwon GC, Menezes ME, Patru MM, Singh K, Ferrari M, Najjar O, Horvath AR, Adeli K, and Lippi G
- Subjects
- Betacoronavirus genetics, Betacoronavirus physiology, COVID-19, Humans, Pandemics, SARS-CoV-2, Coronavirus Infections diagnosis, International Agencies, Molecular Diagnostic Techniques, Pneumonia, Viral diagnosis, Practice Guidelines as Topic
- Abstract
The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection globally has relied extensively on molecular testing, contributing vitally to case identification, isolation, contact tracing, and rationalization of infection control measures during the coronavirus disease 2019 (COVID-19) pandemic. Clinical laboratories have thus needed to verify newly developed molecular tests and increase testing capacity at an unprecedented rate. As the COVID-19 pandemic continues to pose a global health threat, laboratories continue to encounter challenges in the selection, verification, and interpretation of these tests. This document by the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 provides interim guidance on: (A) clinical indications and target populations, (B) assay selection, (C) assay verification, and (D) test interpretation and limitations for molecular testing of SARS-CoV-2 infection. These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide and highlight the continued importance of laboratory medicine in our collective pandemic response.
- Published
- 2020
- Full Text
- View/download PDF
28. PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation.
- Author
-
Roldán DB, Grimmler M, Hartmann C, Hubich-Rau S, Beißert T, Paret C, Cagna G, Rohde C, Wöll S, Koslowski M, Türeci Ö, and Sahin U
- Abstract
PLAC1 (placenta enriched 1) is a mammalian trophoblast-specific protein. Aberrant expression of PLAC1 is observed in various human cancers, where it is involved in the motility, migration, and invasion of tumor cells, which are associated with the phosphoinositide 3-kinase (PI3K)/AKT pathway. We previously demonstrated that AKT activation mediates the downstream effects of PLAC1; however, the molecular mechanisms of PLAC1-induced AKT-mediated tumor-related processes are unclear. We studied human choriocarcinoma and breast cancer cell lines to explore the localization and receptor-ligand interactions, as well as the downstream effects of PLAC1. We show secretion and adherence of PLAC1 to the extracellular matrix, where it forms a trimeric complex with fibroblast growth factor 7 (FGF7) and its receptor, FGF receptor 2 IIIb (FGFR2IIIb). We further show that PLAC1 signaling via FGFR2IIIb activates AKT phosphorylation in cancer cell lines. As the FGF pathway is of major interest in anticancer therapeutic strategies, these data further promote PLAC1 as a promising anticancer drug target., Competing Interests: CONFLICTS OF INTEREST OT was the founder and chief executive officer of Ganymed until the end of 2016, and is currently an employee and chief medical officer of BionTech. In addition, OT holds several patents for the investigational agent, zolbetuximab, with royalties paid to Astellas, and has also received consultancy fees from Astellas Pharma. US was the co-founder and shareholder at Ganymed and also holds several patents, with royalties paid to Astellas. He is currently the founder, chief executive officer, and shareholder of BioNTech. DBR, MG, SH-R, C Hartmann MK, hold a patent EP 2 662 386 A1 licensed to BioNTech AG, TRON gGmbH, Universitätsmedizin der Johannes Gutenberg-Universität Mainz. CR was a former employee of Ganymed. GC, TB, and SW have no conflicts of interest to disclose.
- Published
- 2020
- Full Text
- View/download PDF
29. Direct glucosone-based synthesis and HILIC-ESI-MS/MS characterization of N-terminal fructosylated valine and valylhistidine for validation of enzymatic HbA 1c assays in the diagnosis of diabetes mellitus.
- Author
-
Gerke C, Buchholz M, Müller H, Meusinger R, Grimmler M, and Metzmann E
- Subjects
- Enzyme Assays, Humans, Diabetes Mellitus diagnosis, Fructose chemistry, Glycated Hemoglobin analysis, Histidine chemistry, Ketoses chemistry, Spectrometry, Mass, Electrospray Ionization methods, Tandem Mass Spectrometry methods, Valine chemistry
- Abstract
Naturally occurring fructosamines are of high clinical significance due to their potential use in diabetes mellitus monitoring (quantification of fructosylated hemoglobin, HbA
1c ) or for the investigation of their reactivity in consecutive reactions and harmfulness towards the organism. Here we report the specific synthesis of the fructosylated dipeptide L-valyl-L-histidine (Fru-Val-His) and fructosylated L-valine (Fru-Val). Both are basic tools for the development and validation of enzymatic HbA1c assays. The two fructosamine derivatives were synthesized via a protected glucosone intermediate which was coupled to the primary amine of Val or Val-His, performing a reductive amination reaction. Overall yields starting from fructose were 36% and 34% for Fru-Val and Fru-Val-His, respectively. Both compounds were achieved in purities > 90%. A HILIC-ESI-MS/MS method was developed for routine analysis of the synthesized fructosamines, including starting materials and intermediates. The presented method provides a well-defined and efficient synthesis protocol with purification steps and characterization of the desired products. The functionality of the fructosylated dipeptide has been thoroughly tested in an enzymatic HbA1c assay, showing its concentration-dependent oxidative degradation by fructosyl-peptide oxidases (FPOX). Graphical abstract.- Published
- 2019
- Full Text
- View/download PDF
30. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.
- Author
-
Guderian G, Peter C, Wiesner J, Sickmann A, Schulze-Osthoff K, Fischer U, and Grimmler M
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, HEK293 Cells, HeLa Cells, Humans, Ion Channels genetics, Methylation, Multienzyme Complexes genetics, Protein Binding physiology, Protein Methyltransferases genetics, Protein Serine-Threonine Kinases genetics, Protein-Arginine N-Methyltransferases, Ribonucleoproteins, Small Nuclear genetics, Ribonucleoproteins, Small Nuclear metabolism, Spliceosomes genetics, Spliceosomes metabolism, Substrate Specificity, Ion Channels metabolism, Multienzyme Complexes metabolism, Protein Methyltransferases metabolism, Protein Serine-Threonine Kinases metabolism
- Abstract
Protein arginine methylation plays a critical role in differential gene expression through modulating protein-protein and protein-DNA/RNA interactions. Although numerous proteins undergo arginine methylation, only limited information is available on how protein arginine methyltransferases (PRMTs) identify their substrates. The human PRMT5 complex consists of PRMT5, WD45/MEP50 (WD repeat domain 45/methylosome protein 50), and pICln and catalyzes the symmetrical arginine dimethylation of its substrate proteins. pICln recruits the spliceosomal Sm proteins to the PRMT5 complex for methylation, which allows their subsequent loading onto snRNA to form small nuclear ribonucleoproteins. To understand how the PRMT5 complex is regulated, we investigated its biochemical composition and identified RioK1 as a novel, stoichiometric component of the PRMT5 complex. We show that RioK1 and pICln bind to PRMT5 in a mutually exclusive fashion. This results in a PRMT5-WD45/MEP50 core structure that either associates with pICln or RioK1 in distinct complexes. Furthermore, we show that RioK1 functions in analogy to pICln as an adapter protein by recruiting the RNA-binding protein nucleolin to the PRMT5 complex for its symmetrical methylation. The exclusive interaction of PRMT5 with either pICln or RioK1 thus provides the first mechanistic insight into how a methyltransferase can distinguish between its substrate proteins.
- Published
- 2011
- Full Text
- View/download PDF
31. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy.
- Author
-
Hassel D, Dahme T, Erdmann J, Meder B, Huge A, Stoll M, Just S, Hess A, Ehlermann P, Weichenhan D, Grimmler M, Liptau H, Hetzer R, Regitz-Zagrosek V, Fischer C, Nürnberg P, Schunkert H, Katus HA, and Rottbauer W
- Subjects
- Adult, Aged, Amino Acid Sequence, Animals, Animals, Genetically Modified, Chromosome Aberrations, Chromosomes, Human, Pair 1, Computational Biology, Disease Models, Animal, Embryo, Mammalian, Family Health, Female, Humans, Male, Microfilament Proteins deficiency, Middle Aged, Muscle Contraction genetics, Muscle Fibers, Skeletal, Myocardium pathology, Myocytes, Cardiac metabolism, Polymorphism, Single Nucleotide genetics, Sarcomeres physiology, Zebrafish, Cardiomyopathy, Dilated etiology, Cardiomyopathy, Dilated genetics, Cardiomyopathy, Dilated pathology, Genetic Predisposition to Disease genetics, Microfilament Proteins genetics, Mutation genetics, Myocytes, Cardiac pathology, Sarcomeres genetics
- Abstract
Z-disks, the mechanical integration sites of heart and skeletal muscle cells, link anchorage of myofilaments to force reception and processing. The key molecules that enable the Z-disk to persistently withstand the extreme mechanical forces during muscle contraction have not yet been identified. Here we isolated nexilin (encoded by NEXN) as a novel Z-disk protein. Loss of nexilin in zebrafish led to perturbed Z-disk stability and heart failure. To evaluate the role of nexilin in human heart failure, we performed a genetic association study on individuals with dilated cardiomyopathy and found several mutations in NEXN associated with the disease. Nexilin mutation carriers showed the same cardiac Z-disk pathology as observed in nexilin-deficient zebrafish. Expression in zebrafish of nexilin proteins encoded by NEXN mutant alleles induced Z-disk damage and heart failure, demonstrating a dominant-negative effect and confirming the disease-causing nature of these mutations. Increasing mechanical strain aggravated Z-disk damage in nexilin-deficient skeletal muscle, implying a unique role of nexilin in protecting Z-disks from mechanical trauma.
- Published
- 2009
- Full Text
- View/download PDF
32. Native purification of protein and RNA-protein complexes using a novel affinity procedure.
- Author
-
Kroiss M, Brünger KM, Wiesner J, Grimmler M, Sickmann A, and Fischer U
- Subjects
- Animals, Antibodies, Monoclonal immunology, Cell Line, Drosophila Proteins chemistry, Drosophila Proteins metabolism, Epitopes immunology, Humans, Multiprotein Complexes chemistry, Multiprotein Complexes isolation & purification, Multiprotein Complexes metabolism, Protein Denaturation, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Chromatography, Affinity methods, Drosophila Proteins isolation & purification, Drosophila melanogaster chemistry, RNA-Binding Proteins isolation & purification
- Abstract
Genetic studies in invertebrate model organisms such as Drosophila melanogaster have been a fundament of cell and developmental biology for more than one century. It is mainly the lack of an efficient purification strategy which has hampered biochemical and proteomic analyses of gene products. We describe a novel affinity-tag, termed TagIt-epitope, specifically designed for affinity-purifications of multiprotein complexes from Drosophila. TagIt-fusion proteins can be efficiently purified using a monoclonal antibody and eluted under native conditions by competition with synthetic peptide encompassing the epitope. We demonstrate that this tag is suitable for the purification of proteinaceous assemblies such as the PRMT5-complex and RNA-protein complexes such as snoRNPs from Drosophila Schneider2 cells. Furthermore, we describe a novel approach by which this tag can be used to affinity-purify RNA-binding proteins from cell extracts. Therefore, the TagIt-technique or modifications thereof will be of great value in analyzing macromolecular complexes in Drosophila and also other invertebrates by biochemical means. In addition, RNA-peptide hybrid molecules may become a novel tool to purify RNA binding proteins.
- Published
- 2009
33. Dephosphorylation of survival motor neurons (SMN) by PPM1G/PP2Cgamma governs Cajal body localization and stability of the SMN complex.
- Author
-
Petri S, Grimmler M, Over S, Fischer U, and Gruss OJ
- Subjects
- Amino Acid Sequence, Animals, Cell Nucleus enzymology, HeLa Cells, Humans, Models, Biological, Molecular Sequence Data, Oligonucleotides chemistry, Phosphorylation, Protein Interaction Mapping, Protein Phosphatase 2C, RNA-Binding Proteins, Spliceosomes metabolism, Coiled Bodies metabolism, Motor Neurons metabolism, Neoplasm Proteins metabolism, Phosphoprotein Phosphatases metabolism
- Abstract
The survival motor neuron (SMN) complex functions in maturation of uridine-rich small nuclear ribonucleoprotein (RNP) particles. SMN mediates the cytoplasmic assembly of Sm proteins onto uridine-rich small RNAs, and then participates in targeting RNPs to nuclear Cajal bodies (CBs). Recent studies have suggested that phosphorylation might control localization and function of the SMN complex. Here, we show that the nuclear phosphatase PPM1G/PP2Cgamma interacts with and dephosphorylates the SMN complex. Small interfering RNA knockdown of PPM1G leads to an altered phosphorylation pattern of SMN and Gemin3, loss of SMN from CBs, and reduced stability of SMN. Accumulation in CBs is restored upon overexpression of catalytically active, but not that of inactive, PPM1G. This demonstrates that PPM1G's phosphatase activity is necessary to maintain SMN subcellular distribution. Concomitant knockdown of unr interacting protein (unrip), a component implicated in cytoplasmic retention of the SMN complex, also rescues the localization defects. Our data suggest that an interplay between PPM1G and unrip determine compartment-specific phosphorylation patterns, localization, and function of the SMN complex.
- Published
- 2007
- Full Text
- View/download PDF
34. A comprehensive interaction map of the human survival of motor neuron (SMN) complex.
- Author
-
Otter S, Grimmler M, Neuenkirchen N, Chari A, Sickmann A, and Fischer U
- Subjects
- Carrier Proteins chemistry, Carrier Proteins genetics, Cell Survival genetics, Cell-Free System metabolism, HeLa Cells, Humans, Motor Neurons chemistry, Multiprotein Complexes chemistry, Multiprotein Complexes genetics, Muscular Atrophy, Spinal genetics, Muscular Atrophy, Spinal metabolism, Nuclear Proteins chemistry, Nuclear Proteins genetics, Ribonucleoproteins, Small Nuclear chemistry, Ribonucleoproteins, Small Nuclear genetics, Carrier Proteins metabolism, Models, Molecular, Motor Neurons metabolism, Multiprotein Complexes metabolism, Nuclear Proteins metabolism, Ribonucleoproteins, Small Nuclear metabolism
- Abstract
Assembly of the Sm-class of U-rich small nuclear ribonucleoprotein particles (U snRNPs) is a process facilitated by the macromolecular survival of motor neuron (SMN) complex. This entity promotes the binding of a set of factors, termed LSm/Sm proteins, onto snRNA to form the core structure of these particles. Nine factors, including the SMN protein, the product of the spinal muscular atrophy (SMA) disease gene, Gemins 2-8 and unrip have been identified as the major components of the SMN complex. So far, however, only little is known about the architecture of this complex and the contribution of individual components to its function. Here, we present a comprehensive interaction map of all core components of the SMN complex based upon in vivo and in vitro methods. Our studies reveal a modular composition of the SMN complex with the three proteins SMN, Gemin8, and Gemin7 in its center. Onto this central building block the other components are bound via multiple interactions. Furthermore, by employing a novel assay, we were able to reconstitute the SMN complex from individual components and confirm the interaction map. Interestingly, SMN protein carrying an SMA-causing mutation was severely impaired in formation of the SMN complex. Finally, we show that the peripheral component Gemin5 contributes an essential activity to the SMN complex, most likely the transfer of Sm proteins onto the U snRNA. Collectively, the data presented here provide a basis for the detailed mechanistic and structural analysis of the assembly machinery of U snRNPs.
- Published
- 2007
- Full Text
- View/download PDF
35. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
- Author
-
Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, Jäkel H, Kullmann M, Kriwacki RW, and Hengst L
- Subjects
- Animals, Binding Sites genetics, Cyclin-Dependent Kinase 2 genetics, Cyclin-Dependent Kinase 2 metabolism, Cyclin-Dependent Kinase Inhibitor p27 genetics, Cyclin-Dependent Kinases antagonists & inhibitors, Cyclin-Dependent Kinases genetics, Fibroblasts, Fusion Proteins, bcr-abl, HeLa Cells, Humans, Mice, Phosphorylation, Protein Binding genetics, Protein Structure, Tertiary genetics, Protein-Tyrosine Kinases genetics, Protein-Tyrosine Kinases metabolism, S-Phase Kinase-Associated Proteins genetics, S-Phase Kinase-Associated Proteins metabolism, SKP Cullin F-Box Protein Ligases genetics, SKP Cullin F-Box Protein Ligases metabolism, Signal Transduction physiology, src-Family Kinases genetics, Cell Transformation, Neoplastic genetics, Cyclin-Dependent Kinase Inhibitor p27 metabolism, Cyclin-Dependent Kinases metabolism, Gene Expression Regulation, Neoplastic genetics, Oncogenes genetics, src-Family Kinases metabolism
- Abstract
p27Kip1 controls cell proliferation by binding to and regulating the activity of cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are regulated through direct phosphorylation by tyrosine kinases. A conserved tyrosine residue (Y88) in the Cdk-binding domain of p27 can be phosphorylated by the Src-family kinase Lyn and the oncogene product BCR-ABL. Y88 phosphorylation does not prevent p27 binding to cyclin A/Cdk2. Instead, it causes phosphorylated Y88 and the entire inhibitory 3(10)-helix of p27 to be ejected from the Cdk2 active site, thus restoring partial Cdk activity. Importantly, this allows Y88-phosphorylated p27 to be efficiently phosphorylated on threonine 187 by Cdk2 which in turn promotes its SCF-Skp2-dependent degradation. This direct link between transforming tyrosine kinases and p27 may provide an explanation for Cdk kinase activities observed in p27 complexes and for premature p27 elimination in cells that have been transformed by activated tyrosine kinases.
- Published
- 2007
- Full Text
- View/download PDF
36. Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart.
- Author
-
Bendig G, Grimmler M, Huttner IG, Wessels G, Dahme T, Just S, Trano N, Katus HA, Fishman MC, and Rottbauer W
- Subjects
- Actinin physiology, Amino Acid Sequence, Animals, Atrial Natriuretic Factor antagonists & inhibitors, Atrial Natriuretic Factor biosynthesis, Atrial Natriuretic Factor genetics, Calcium metabolism, Down-Regulation genetics, Genetic Markers, Humans, Mechanotransduction, Cellular genetics, Molecular Sequence Data, Myocardial Contraction genetics, Protein Serine-Threonine Kinases deficiency, Protein Serine-Threonine Kinases genetics, Vascular Endothelial Growth Factor A antagonists & inhibitors, Vascular Endothelial Growth Factor A biosynthesis, Vascular Endothelial Growth Factor A genetics, Mechanotransduction, Cellular physiology, Myocardial Contraction physiology, Myocardium enzymology, Protein Serine-Threonine Kinases physiology, Zebrafish embryology
- Abstract
The vertebrate heart possesses autoregulatory mechanisms enabling it first to sense and then to adapt its force of contraction to continually changing demands. The molecular components of the cardiac mechanical stretch sensor are mostly unknown but of immense medical importance, since dysfunction of this sensing machinery is suspected to be responsible for a significant proportion of human heart failure. In the hearts of the ethylnitros-urea (ENU)-induced, recessive embryonic lethal zebrafish heart failure mutant main squeeze (msq), we find stretch-responsive genes such as atrial natriuretic factor (anf) and vascular endothelial growth factor (vegf) severely down-regulated. We demonstrate through positional cloning that heart failure in msq mutants is due to a mutation in the integrin-linked kinase (ilk) gene. ILK specifically localizes to costameres and sarcomeric Z-discs. The msq mutation (L308P) reduces ILK kinase activity and disrupts binding of ILK to the Z-disc adaptor protein beta-parvin (Affixin). Accordingly, in msq mutant embryos, heart failure can be suppressed by expression of ILK, and also of a constitutively active form of Protein Kinase B (PKB), and VEGF. Furthermore, antisense-mediated abrogation of zebrafish beta-parvin phenocopies the msq phenotype. Thus, we provide evidence that the heart uses the Integrin-ILK-beta-parvin network to sense mechanical stretch and respond with increased expression of ANF and VEGF, the latter of which was recently shown to augment cardiac force by increasing the heart's calcium transients.
- Published
- 2006
- Full Text
- View/download PDF
37. Unrip, a factor implicated in cap-independent translation, associates with the cytosolic SMN complex and influences its intracellular localization.
- Author
-
Grimmler M, Otter S, Peter C, Müller F, Chari A, and Fischer U
- Subjects
- Carrier Proteins chemistry, Carrier Proteins metabolism, Coiled Bodies, DNA-Binding Proteins metabolism, HeLa Cells, Humans, Multiprotein Complexes chemistry, Neoplasm Proteins chemistry, Protein Binding, Protein Transport, RNA Caps physiology, RNA Interference, Recombinant Fusion Proteins, Ribonucleoproteins, Small Nuclear metabolism, SMN Complex Proteins, Cyclic AMP Response Element-Binding Protein metabolism, Cytoplasm metabolism, Multiprotein Complexes metabolism, Neoplasm Proteins metabolism, Nerve Tissue Proteins metabolism, Protein Biosynthesis, RNA-Binding Proteins metabolism
- Abstract
Spliceosomal Uridine-rich small ribonucleo protein (U snRNP) assembly is an active process mediated by the macromolecular survival motor neuron (SMN) complex. This complex contains the SMN protein and six additional proteins, named Gemin2-7, according to their localization to nuclear structures termed gems. Here, we provide biochemical evidence for the existence of another, yet atypical, SMN complex component, termed unr-interacting protein (unrip). This abundant factor has been previously shown to form a complex with unr, a protein implicated in cap-independent translation of cellular and viral mRNA. We show that unrip is integrated into a complex with unr or with the SMN complex in vivo in a mutually exclusive manner. In the latter case, unrip is recruited to the active SMN complex via a stable interaction with Gemin7. However, unlike SMN and Gemins, unrip localizes predominantly to the cytoplasm and is absent from gems/Cajal bodies. Interestingly, RNAi-induced reduction of unrip protein levels leads to enhanced accumulation of SMN in the nucleus as evident by the increased formation of nuclear gems/Cajal bodies. Our data identify unrip as the first component of the U snRNP assembly machinery that associates with the SMN complex in a compartment-specific way. We speculate that unrip plays a crucial role in the intracellular distribution of the SMN complex.
- Published
- 2005
- Full Text
- View/download PDF
38. Phosphorylation regulates the activity of the SMN complex during assembly of spliceosomal U snRNPs.
- Author
-
Grimmler M, Bauer L, Nousiainen M, Körner R, Meister G, and Fischer U
- Subjects
- Amino Acid Sequence, Cyclic AMP Response Element-Binding Protein chemistry, Cyclic AMP Response Element-Binding Protein genetics, HeLa Cells, Humans, Molecular Sequence Data, Multiprotein Complexes chemistry, Multiprotein Complexes metabolism, Nerve Tissue Proteins chemistry, Nerve Tissue Proteins genetics, Phosphorylation, Protein Binding, Protein Methyltransferases metabolism, Protein-Arginine N-Methyltransferases, RNA-Binding Proteins chemistry, RNA-Binding Proteins genetics, SMN Complex Proteins, Sequence Alignment, Cyclic AMP Response Element-Binding Protein metabolism, Nerve Tissue Proteins metabolism, RNA-Binding Proteins metabolism, Ribonucleoproteins, Small Nuclear metabolism, Spliceosomes metabolism, Uridine metabolism
- Abstract
The assembly of spliceosomal U-rich small nuclear ribonucleoproteins (U snRNPs) is an ATP-dependent process mediated by the coordinated action of the SMN and the PRMT5 complex. Here, we provide evidence that the activity of this assembly machinery is regulated by means of post-translational modification. We show that two main components of the SMN/PRMT5 system, namely the survival motor neuron (SMN) protein (reduced levels thereof causing spinal muscular atrophy) and pICln, are phosphorylated in vivo. Both proteins share a previously unknown motif containing either one or two phosphoserines. Alteration of these residues in SMN (serines 28 and 31) significantly impairs the activity of the SMN complex. Despite the presence of SMN in both the nucleus and cytoplasm, we find that only the latter promotes efficient SMN-mediated U snRNP assembly activity. As cytoplasmic SMN is phosphorylated to a much larger extent, we hypothesize that this modification is a key activator of the SMN complex.
- Published
- 2005
- Full Text
- View/download PDF
39. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis.
- Author
-
Pendergraft WF 3rd, Rudolph EH, Falk RJ, Jahn JE, Grimmler M, Hengst L, Jennette JC, and Preston GA
- Subjects
- Caspases metabolism, Cells, Cultured, Cyclin-Dependent Kinase Inhibitor p21, Endothelium, Vascular cytology, G1 Phase physiology, Granzymes, Humans, Inflammation metabolism, Myeloblastin, Resting Phase, Cell Cycle physiology, Substrate Specificity, Umbilical Veins cytology, Apoptosis physiology, Cyclins metabolism, Serine Endopeptidases metabolism
- Abstract
Background: Emerging data raise possibilities of a complex and specific biologic role for leukocyte-derived proteases in substrate processing and in signaling pathways. Neutrophil proteinase 3 (PR3) is a caspase-like protease that enters endothelial cells, cleaves nuclear factor-kappaB (NF-kappaB), and induces sustained JNK activation, implying that the major cell cycle inhibitor p21 may be inactivated. Cleavage of p21 by caspase-3 is reported to be required for endothelial cell apoptosis. We hypothesized that PR3 may target p21., Methods: Human umbilical vein endothelial cells (HUVEC) were treated with or without PR3 (5 microg/mL) from 0 hours or up to 8 hours, and analyzed for changes in cell cycle control proteins by immunoblotting, immunofluorescence and flow cytometry., Results: PR3 exposure resulted in cleavage of p21 between Thr80 and Gly81, loss of nuclear p21 by cytoplasmic sequestration and depletion of p21 from cyclin/cyclin-dependent kinase (CDK) complexes. Examination of cyclins D and E, p53, Rb, and p27 revealed a largely nonproliferative expression profile. Cells arrested in G1 were more susceptible to PR3 effects. We examined inflamed human colonic tissue and found a fragment similar in size to that generated by PR3 in HUVEC. Granzyme B, a T-cell homologue of PR3 that cleaves caspase substrates, also cleaves p21 between Asp62 and Phe63. A reported substrate of granzyme B and caspases, Bid, is cleaved by PR3 signifying commonality of substrates among these proteases., Conclusion: A theme is developing that the granulocyte protease, PR3, is an exogenous caspase-like molecule that can sidestep intracellular caspase functions at sites of inflammation.
- Published
- 2004
- Full Text
- View/download PDF
40. Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN complex and the role of a new component, Lsm11, in histone RNA processing.
- Author
-
Pillai RS, Grimmler M, Meister G, Will CL, Lührmann R, Fischer U, and Schümperli D
- Subjects
- Amino Acid Sequence, Animals, Autoantigens, Histones biosynthesis, Humans, Mice, Molecular Sequence Data, RNA-Binding Proteins, Ribonucleoprotein, U7 Small Nuclear biosynthesis, Sequence Alignment, snRNP Core Proteins, Histones genetics, RNA Processing, Post-Transcriptional, Ribonucleoprotein, U7 Small Nuclear chemistry, Ribonucleoproteins, Small Nuclear genetics, Ribonucleoproteins, Small Nuclear metabolism
- Abstract
A set of seven Sm proteins assemble on the Sm-binding site of spliceosomal U snRNAs to form the ring-shaped Sm core. The U7 snRNP involved in histone RNA 3' processing contains a structurally similar but biochemically unique Sm core in which two of these proteins, Sm D1 and D2, are replaced by Lsm10 and by another as yet unknown component. Here we characterize this factor, termed Lsm11, as a novel Sm-like protein with apparently two distinct functions. In vitro studies suggest that its long N-terminal part mediates an important step in histone mRNA 3'-end cleavage, most likely by recruiting a zinc finger protein previously identified as a processing factor. In contrast, the C-terminal part, which comprises two Sm motifs interrupted by an unusually long spacer, is sufficient to assemble with U7, but not U1, snRNA. Assembly of this U7-specific Sm core depends on the noncanonical Sm-binding site of U7 snRNA. Moreover, it is facilitated by a specialized SMN complex that contains Lsm10 and Lsm11 but lacks Sm D1/D2. Thus, the U7-specific Lsm11 protein not only specifies the assembly of the U7 Sm core but also fulfills an important role in U7 snRNP-mediated histone mRNA processing.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.